The tariff classification of Tamoxifen citrate (CAS-54965-24-1); Tolbutamide (CAS-64-77-7); and Xylazine hydrochloride (CAS-23076-35-9), all in bulk form, from Ireland, Italy andSwitzerland, respectively
Reasoning
The tariff classification of Tamoxifen citrate (CAS-54965-24-1); Tolbutamide (CAS-64-77-7); and Xylazine hydrochloride (CAS-23076-35-9), all in bulk form, from Ireland, Italy andSwitzerland, respectively
Cite this ruling
CBP Ruling 810509 (2935006000): The tariff classification of Tamoxifen citrate (CAS-54965-24-1); Tolbutamide (CAS-64-77-7); and Xylazine hydrochloride (CAS-23076-35-9), all in bulk form, from Ireland, Italy andSwitzerland, respectively
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293500
The tariff classification of Dichloramine B (CAS 473-29-0) from France.
The tariff classification of Metolazone (CAS-17560-51-9), imported in bulk form, from Italy
The tariff classification of Glimepiride (CAS-93479-97-1), imported in bulk form, from Spain
The tariff classification of Dorzolamide Hydrochloride (CAS-130693-82-2) and Propranolol Hydrochloride (CAS-318-98-9), imported in bulk form, from India
The tariff classification of 3-Bromobenzenesulphonamide (CAS 89599-01-9) from China.